NL6707702A - - Google Patents

Info

Publication number
NL6707702A
NL6707702A NL6707702A NL6707702A NL6707702A NL 6707702 A NL6707702 A NL 6707702A NL 6707702 A NL6707702 A NL 6707702A NL 6707702 A NL6707702 A NL 6707702A NL 6707702 A NL6707702 A NL 6707702A
Authority
NL
Netherlands
Application number
NL6707702A
Other versions
NL159283B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6707702A publication Critical patent/NL6707702A/xx
Publication of NL159283B publication Critical patent/NL159283B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
NL6707702.A 1966-06-08 1967-06-02 Werkwijze ter bereiding van een injecteerbaar preparaat. NL159283B (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB25595/66A GB1171125A (en) 1966-06-08 1966-06-08 Improvements in or relating to Injectable Preparations

Publications (2)

Publication Number Publication Date
NL6707702A true NL6707702A (cg-RX-API-DMAC7.html) 1967-12-11
NL159283B NL159283B (nl) 1979-02-15

Family

ID=10230237

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6707702.A NL159283B (nl) 1966-06-08 1967-06-02 Werkwijze ter bereiding van een injecteerbaar preparaat.

Country Status (6)

Country Link
US (1) US3384544A (cg-RX-API-DMAC7.html)
BE (1) BE699678A (cg-RX-API-DMAC7.html)
FR (1) FR7316M (cg-RX-API-DMAC7.html)
GB (1) GB1171125A (cg-RX-API-DMAC7.html)
IT (1) IT1035004B (cg-RX-API-DMAC7.html)
NL (1) NL159283B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2104740A1 (cg-RX-API-DMAC7.html) * 1970-03-17 1972-04-21 Merck & Co Inc

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3678149A (en) * 1970-01-26 1972-07-18 Samuel J Prigal Method of enhancing the action of a medicament
GB1502774A (en) * 1974-06-25 1978-03-01 Nat Res Dev Immunological preparations
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
US4530832A (en) * 1978-12-07 1985-07-23 Schering Corporation Method of vaccination for prevention of Bordetella bronchiseptica infection
EP0059521B1 (en) * 1981-03-03 1985-01-02 Centraal Diergeneeskundig Instituut Water-in-oil emulsion for use in the potentation of the immune system of animals
FR2501526A1 (fr) * 1981-03-13 1982-09-17 Montagne Noire Produits Chimiq Nouveaux emulsionnants et leur application pour la production de vaccins
US4707470A (en) * 1985-05-17 1987-11-17 Smithkline Beckman Corporation Polyene antibiotic emulsion formulation
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
ATE183099T1 (de) * 1991-04-19 1999-08-15 Lds Technologies Inc Konvertierbare mikroemulsionsverbindungen
ATE233547T1 (de) * 1991-06-26 2003-03-15 Yamanouchi Europ Bv Vesiculae in nichtpolaren medien
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
ES2098739T3 (es) 1992-05-13 1997-05-01 Sandoz Ltd Composiciones oftalmicas conteniendo una cyclosporin.
EP0589843B1 (en) 1992-09-25 2001-11-28 Novartis AG Pharmaceutical compositions containing cyclosporins
EP0671937A4 (en) * 1992-10-16 1996-09-18 Smithkline Beecham Corp COMPOSITIONS FOR PHARMACEUTICAL EMULSIONS.
DK17093D0 (da) * 1993-02-15 1993-02-15 Lyfjathroun H F Farmaceutisk praeparat til topisk administrering af antigener og/eller vacciner til pattedyr via slimhinder
ES2177652T3 (es) 1994-11-03 2002-12-16 Novartis Ag Nuevas formas de preparacion de ciclosporina para la aplicacion oral con composicion simple y alta biodisponibilidad, y procedimiento para su obtencion.
SI0750907T1 (en) * 1995-06-30 2002-08-31 American Cyanamid Company Stable macrolide and macrolide vaccine compositions
DE19544507B4 (de) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
US6245349B1 (en) 1996-02-23 2001-06-12 éLAN CORPORATION PLC Drug delivery compositions suitable for intravenous injection
CA2259469A1 (en) 1996-06-05 1997-12-11 Ashmont Holdings Limited Injectable compositions
EP1331002A3 (en) 1997-01-30 2004-01-14 Novartis AG Oil-free pharmaceutical compositions containing cyclosporin A
CA2306090A1 (en) * 1997-10-24 1999-05-06 Christopher W. Mcdaniel Delivery vehicles for bioactive agents and uses thereof
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US8703095B2 (en) * 2005-07-07 2014-04-22 Sanofi Pasteur S.A. Immuno-adjuvant emulsion

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE25721E (en) * 1965-01-26 Swine erysipelas vaccine
US2966443A (en) * 1959-06-22 1960-12-27 American Cyanamid Co Trivalent poliomyelitis live virus vaccine
US3099601A (en) * 1959-10-02 1963-07-30 Anchor Serum Company Bacterin in aqueous polyethylene, mineral oil emulsion
US3096249A (en) * 1960-05-10 1963-07-02 Samuel J Prigal Emulsion composition
GB914894A (en) * 1960-08-12 1963-01-09 Beecham Res Lab Injectable pharmaceutical media
US3149036A (en) * 1961-10-16 1964-09-15 Merck & Co Inc Adjuvant vaccine with aluminum monostearate, mannide monooleate, vegetable oil, and an aqueous phase immunolgical agent
US3185625A (en) * 1961-11-08 1965-05-25 Brown Ethan Allan Injectionable substances

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2104740A1 (cg-RX-API-DMAC7.html) * 1970-03-17 1972-04-21 Merck & Co Inc

Also Published As

Publication number Publication date
IT1035004B (it) 1979-10-20
NL159283B (nl) 1979-02-15
DE1617502A1 (de) 1972-02-10
BE699678A (cg-RX-API-DMAC7.html) 1967-12-08
US3384544A (en) 1968-05-21
GB1171125A (en) 1969-11-19
FR7316M (cg-RX-API-DMAC7.html) 1969-10-06

Similar Documents

Publication Publication Date Title
FR7316M (cg-RX-API-DMAC7.html)
AU5917865A (cg-RX-API-DMAC7.html)
AU424443B2 (cg-RX-API-DMAC7.html)
AU428063B2 (cg-RX-API-DMAC7.html)
AU421822B2 (cg-RX-API-DMAC7.html)
AU414526B2 (cg-RX-API-DMAC7.html)
AU415165B1 (cg-RX-API-DMAC7.html)
AU417216B2 (cg-RX-API-DMAC7.html)
AU433222B2 (cg-RX-API-DMAC7.html)
AU5895065A (cg-RX-API-DMAC7.html)
AU612166A (cg-RX-API-DMAC7.html)
AU6703465A (cg-RX-API-DMAC7.html)
BE692383A (cg-RX-API-DMAC7.html)
BE680879A (cg-RX-API-DMAC7.html)
AU6852465A (cg-RX-API-DMAC7.html)
BE694238A (cg-RX-API-DMAC7.html)
BE693026A (cg-RX-API-DMAC7.html)
BE692888A (cg-RX-API-DMAC7.html)
AU855865A (cg-RX-API-DMAC7.html)
BE692819A (cg-RX-API-DMAC7.html)
AU433620A (cg-RX-API-DMAC7.html)
BE692633A (cg-RX-API-DMAC7.html)
BE694626A (cg-RX-API-DMAC7.html)
BE688932A (cg-RX-API-DMAC7.html)
BE683865A (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
VJC Lapsed due to non-payment of the due maintenance fee for the patent or patent application
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: GLAXO LAB